Most Clicked StoriesMore >


C.R. Bard to be acquired by Becton Dickinson in $24B deal

AdvaMed SmartBrief | Apr 24, 2017

Becton Dickinson has agreed to pay $24 billion for C.R. Bard, a maker of catheters and implantable heart devices, in a cash-and-stock deal that represents a 25.2% premium over Bard's April 21 closing price and that is expected to be completed this fall. BD is creating a new unit, BD Interventional, into which it intends to integrate Bard's businesses, and the unit will be overseen by newly promoted BD President Tom Polen. The Wall Street Journal (tiered subscription model) (04/23) The Associated Press (04/23) Xconomy (04/24)


Medtech companies seek to pull new-gen stents from Indian market

AdvaMed SmartBrief | Apr 25, 2017

Sunshine Heart gets $9.2M boost

AdvaMed SmartBrief | Apr 25, 2017

Small CPAP device debuted by ResMed for travel use

AdvaMed SmartBrief | Apr 26, 2017

Offering could pull in $40M for Reva Medical

AdvaMed SmartBrief | Apr 26, 2017

Avedro gets $42M boost

AdvaMed SmartBrief | Apr 28, 2017

Endoscopy equipment market poised for growth

AdvaMed SmartBrief | Apr 26, 2017

MHRA releases 2017-2018 post-Brexit business plan

AdvaMed SmartBrief | Apr 24, 2017

Medtech companies' request to pull latest stents denied by Indian regulator

AdvaMed SmartBrief | Apr 27, 2017

Stimwave tapped to supply spinal cord stimulation systems to DOD

AdvaMed SmartBrief | Apr 24, 2017


Find AdvaMed SmartBrief Issues by Date:



ADVAMED News More >


Start saving with the AdvaMed Purchasing Group

AdvaMed SmartBrief | Apr 28, 2017

2017 Women's Executive Network Conference

AdvaMed SmartBrief | Apr 28, 2017

AdvaMed 2017 Payment Policy Conference

AdvaMed SmartBrief | Apr 27, 2017

Executive Communications Workshop

AdvaMed SmartBrief | Apr 26, 2017

Integrating Human Factors Into Medical Device Design Control And Beyond Workshop

AdvaMed SmartBrief | Apr 25, 2017




Sign up for AdvaMed SmartBrief



Designed specifically for manufacturers of medical devices, health care information systems and diagnostic products, AdvaMed SmartBrief is a FREE e-mail newsletter. By providing a summary of the day's most important medical technologies news, AdvaMed SmartBrief saves you time and keeps you smart. Learn more

Recent Poll view more polls


What concerns should medical device companies focus on in the coming year?

Chart.